Complications of androgen-deprivation therapy in prostate cancer: the other side of the coin.
Hoffmann
Paul
P
Department of Urology, University Clinics of Brussels, Erasme Hospital, Belgium.
Schulman
Claude
C
D000328:Adult; D000368:Aged; D000726:Androgen Antagonists / Q000009:adverse effects* / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000139:chemically induced*; D002423:Cause of Death; D006801:Humans; D007006:Hypogonadism / Q000139:chemically induced*; D008297:Male; D024821:Metabolic Syndrome / Q000139:chemically induced*; D008875:Middle Aged; D009376:Neoplasms, Hormone-Dependent / Q000188:drug therapy*; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000401:mortality
D000726:Androgen Antagonists